Table 3.

Retrospective assessment and tumour characteristics

Retrospectively detected tumours
Blinded
No. of CTHA scans with additional tumours (%)	24 (39%)
No. of concomitant true-positive CRLM, N (%)	56 (93.3%)
No. of false-positive lesions scored on CTHA, N (%)	4 (6.7%)
Unblinded
No. of concomitant true-positive CRLM, N	69
Tumour characteristics (N = 56)
Enhancing ring, N (%)	42 (75.0%)
Hypodense tumour, N (%)	2 (3.5%)
Hyperdense tumour, N (%)	8 (14.0%)
Mixed attenuation, N (%)	2 (3.5%)
A specific nodule, N (%)	2 (3.5%)